Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment

SYK/JAK 双重抑制可克服慢性淋巴细胞白血病中的依布替尼耐药性：Cerdulatinib 而非依布替尼可诱导受微环境保护的肿瘤细胞凋亡